{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["liposome", "otitis externa", "otological preparations", "ozone"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "37511695", "DateRevised": {"Year": "2023", "Month": "08", "Day": "01"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "06", "Day": "29"}], "ELocationID": ["1083", "10.3390/jpm13071083"], "Journal": {"ISSN": "2075-4426", "JournalIssue": {"Volume": "13", "Issue": "7", "PubDate": {"Year": "2023", "Month": "Jun", "Day": "29"}}, "Title": "Journal of personalized medicine", "ISOAbbreviation": "J Pers Med"}, "ArticleTitle": "Perspectives of Italian Physicians and Patients in the Treatment of Otitis Externa: A Real-Life Study.", "Abstract": {"AbstractText": ["(1) Background: Otitis externa (OE) is a common inflammatory disease of the external ear canal. Given the numerous manifestations of OE, the high rate of recurrence of the disease, as well as the emergence of resistance to antibiotics, therapeutic strategies are numerous and still not well standardized. The aim of this study was to investigate the patient journey of Italian patients suffering from OE, paying greater attention to new therapeutic options. (2) Methods: We conducted a national survey to evaluate the characteristics of patients affected by OE and to analyze the most-prescribed treatments. (3) Results: OE is a common, often relapsing disease that has several clinical manifestations. Prior to observation, the combination of corticosteroids and topical antibiotics was the most common therapeutic strategy. At the time of observation, new liposomal ozone-based preparations were the most-prescribed treatment. (4) Conclusions: This multi-center study investigated key aspects of the OE patient journey, highlighting the growing problem of antibiotic resistance. Restoring a correct ear microbiome is the therapeutic goal. In this context, new liposomal ozone-based drugs represent a promising therapeutic strategy."]}, "AuthorList": [{"Identifier": ["0000-0003-4406-0008"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit of Otolaryngology, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy."}], "LastName": "Gelardi", "ForeName": "Matteo", "Initials": "M"}, {"Identifier": ["0000-0002-5082-7271"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit of Otolaryngology, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy."}], "LastName": "Giancaspro", "ForeName": "Rossana", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Paediatric National Healthcare System, 10135 Torino, Italy."}], "LastName": "Landi", "ForeName": "Massimo", "Initials": "M"}, {"Identifier": ["0000-0002-6120-3894"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "General Practitioner, Local Health Department Bari, 70026 Modugno, Italy."}], "LastName": "Santoiemma", "ForeName": "Luigi", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Chemist, 00143 Rome, Italy."}], "LastName": "Balestra", "ForeName": "Maddalena", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit of Otolaryngology, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy."}], "LastName": "Cassano", "ForeName": "Michele", "Initials": "M"}, {"Identifier": ["0000-0001-9507-9126"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy."}], "LastName": "Rizzo", "ForeName": "Roberta", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "J Pers Med", "NlmUniqueID": "101602269", "ISSNLinking": "2075-4426"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Acute Otitis Externa (Swimmer\u2019s Ear) Am. Fam. Physician. 2023;107:Online.", "ArticleIdList": ["36791446"]}, {"Citation": "Medina-Blasini Y., Sharman T. StatPearls. StatPearls Publishing; Tampa, FL, USA: 2023. Otitis Externa.", "ArticleIdList": ["32310515"]}, {"Citation": "Hajioff D., MacKeith S. Otitis externa. BMJ Clin. Evid. 2015;2015:510.", "ArticleIdList": ["PMC4466798", "26074134"]}, {"Citation": "Rosenfeld R.M., Schwartz S.R., Cannon C.R., Roland P.S., Simon G.R., Kumar K.A., Huang W.W., Haskell H.W., Robertson P.J. Clinical practice guideline: Acute otitis externa. Otolaryngol. Head Neck Surg. 2014;150:S1\u2013S24. doi: 10.1177/0194599813514365.", "ArticleIdList": ["10.1177/0194599813514365", "24491310"]}, {"Citation": "Kim S.K., Han S.J., Hong S.J., Hong S.M. Microbiome of Acute Otitis Externa. J. Clin. Med. 2022;11:7074. doi: 10.3390/jcm11237074.", "ArticleIdList": ["10.3390/jcm11237074", "PMC9740316", "36498648"]}, {"Citation": "Luthra H., Sharma V., Jindal N. Microbiological Profile and Antibiotic Sensitivity of 100 Cases of Otitis Externa. Indian J. Otolaryngol. Head Neck Surg. 2022;74:3616\u20133619. doi: 10.1007/s12070-020-02151-x.", "ArticleIdList": ["10.1007/s12070-020-02151-x", "PMC9895417", "36742823"]}, {"Citation": "Lee J.S., Lee S.M., Son H.S., Na Yoon Y., Shin J.E., Sul W.J., Yu D.A., Choe Y.B., Lee Y.W. Analysis of the Microbiome of the Ear Canal in Normal Individuals and Patients with Chronic Otitis Externa. Ann. Dermatol. 2022;34:461\u2013471. doi: 10.5021/ad.22.153.", "ArticleIdList": ["10.5021/ad.22.153", "PMC9763917", "36478428"]}, {"Citation": "Rasheed A.M., Hilal S.A., Abbas A.M. Is adding an oral antibiotic with the topical antibiotic steroid useful in treatment of uncomplicated acute otitis externa in immunocompetent patients? J. Popul. Ther. Clin. Pharmacol. 2022;29:e27\u2013e32.", "ArticleIdList": ["35848194"]}, {"Citation": "Ugazio E., Tullio V., Binello A., Tagliapietra S., Dosio F. Ozonated Oils as Antimicrobial Systems in Topical Applications. Their Characterization, Current Applications, and Advances in Improved Delivery Techniques. Mol. Basel Switz. 2020;25:334. doi: 10.3390/molecules25020334.", "ArticleIdList": ["10.3390/molecules25020334", "PMC7024311", "31947580"]}, {"Citation": "Jackson E.A., Geer K. Acute Otitis Externa: Rapid Evidence Review. Am. Fam. Physician. 2023;107:145\u2013151.", "ArticleIdList": ["36791445"]}, {"Citation": "Chu L., Acosta A.M., Aazami H., Dennis P., De Valle O., Ehmer D., Hedrick J.A., Ansley J.F. Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Among Patients with Acute Otitis Externa: A Randomized Clinical Trial. JAMA Netw. Open. 2022;5:e2221699. doi: 10.1001/jamanetworkopen.2022.21699.", "ArticleIdList": ["10.1001/jamanetworkopen.2022.21699", "35834251"]}, {"Citation": "Ansley J., Mair E.A., Namini H., Lu C.H., LeBel C. OTO-201 for the Treatment of Acute Otitis Externa: Results from a Phase 3 Randomized Clinical Study. Ann. Otol. Rhinol. Laryngol. 2019;128:524\u2013533. doi: 10.1177/0003489419830116.", "ArticleIdList": ["10.1177/0003489419830116", "30829050"]}, {"Citation": "Lorente J., Sabater F., Rivas M.P., Fuste J., Risco J., G\u00f3mez M. Ciprofloxacin plus fluocinolone acetonide versus ciprofloxacin alone in the treatment of diffuse otitis externa. J. Laryngol. Otol. 2014;128:591\u2013598. doi: 10.1017/S0022215114001157.", "ArticleIdList": ["10.1017/S0022215114001157", "25000552"]}, {"Citation": "Panahi Y., Akhavan A., Sahebkar A., Hosseini S.M., Taghizadeh M., Akbari H., Sharif M.R., Imani S. Investigation of the effectiveness of Syzygium aromaticum, Lavandula angustifolia and Geranium robertianum essential oils in the treatment of acute external otitis: A comparative trial with ciprofloxacin. J. Microbiol. Immunol. Infect. 2014;47:211\u2013216. doi: 10.1016/j.jmii.2012.10.002.", "ArticleIdList": ["10.1016/j.jmii.2012.10.002", "23274083"]}, {"Citation": "Mostafa M.G., Ahmed S., Islam M.R., Rahman M.A., Khan L., Alam M.M., Ahmed M.B. Efficacy of Clotrimazole 1% Solution Compared to Econazole Nitrate 1% + Triamcinolone Acetonide 0.1% Cream in Patient with Otomycosis. Mymensingh Med. J. MMJ. 2021;30:638\u2013643.", "ArticleIdList": ["34226449"]}, {"Citation": "Koltsidopoulos P., Skoulakis C. Otomycosis with Tympanic Membrane Perforation: A Review of the Literature. Ear. Nose. Throat J. 2020;99:518\u2013521. doi: 10.1177/0145561319851499.", "ArticleIdList": ["10.1177/0145561319851499", "31142158"]}, {"Citation": "Bance M., Rutka J.A. Topical treatment for otorrhea: Issues and controversies. J. Otolaryngol. 2005;34:S52\u2013S55.", "ArticleIdList": ["16076416"]}, {"Citation": "Dirain C.O., Antonelli P.J. Cytotoxicity of Tetracyclines in Human Tympanic Membrane Fibroblasts. Otol. Neurotol. 2023;44:520\u2013524. doi: 10.1097/MAO.0000000000003867.", "ArticleIdList": ["10.1097/MAO.0000000000003867", "37026784"]}, {"Citation": "Jinn T.H., Kim P.D., Russell P.T., Church C.A., John E.O., Jung T.T.K. Determination of ototoxicity of common otic drops using isolated cochlear outer hair cells. Laryngoscope. 2001;111:2105\u20132108. doi: 10.1097/00005537-200112000-00004.", "ArticleIdList": ["10.1097/00005537-200112000-00004", "11802005"]}, {"Citation": "Burton M., Krumbeck J.A., Wu G., Tang S., Prem A., Gupta A.K., Dawson Jr T.L. The adult microbiome of healthy and otitis patients: Definition of the core healthy and diseased ear microbiomes. PLoS ONE. 2022;17:e0262806. doi: 10.1371/journal.pone.0262806.", "ArticleIdList": ["10.1371/journal.pone.0262806", "PMC8786117", "35073343"]}, {"Citation": "Villedieu A., Papesh E., Weinberg S.E., Teare L., Radhakrishnan J., Elamin W.F. Seasonal variation of Pseudomonas aeruginosa in culture positive otitis externa in South East England. Epidemiol. Infect. 2018;146:1811\u20131812. doi: 10.1017/S0950268818001899.", "ArticleIdList": ["10.1017/S0950268818001899", "PMC9506700", "29976272"]}, {"Citation": "Fusconi M., Petrozza V., Taddei A.R., Vinciguerra V., De Virgilio A., Chiarini F., Cirenza M., Gallinell C., Conte M., De Vincentiis M. Is biofilm the cause of chronic otitis externa? Laryngoscope. 2011;121:2626\u20132633. doi: 10.1002/lary.22348.", "ArticleIdList": ["10.1002/lary.22348", "22109763"]}, {"Citation": "Bruins M.J., Wijshake D., de Vries-van Rossum S.V., Klein Overmeen R.G.J., Ruijs G.J.H.M. Otitis externa following aural irrigation linked to instruments contaminated with Pseudomonas aeruginosa. J. Hosp. Infect. 2013;84:222\u2013226. doi: 10.1016/j.jhin.2013.04.010.", "ArticleIdList": ["10.1016/j.jhin.2013.04.010", "23764317"]}, {"Citation": "Hajjartabar M. Poor-quality water in swimming pools associated with a substantial risk of otitis externa due to Pseudomonas aeruginosa. Water Sci. Technol. 2004;50:63\u201367. doi: 10.2166/wst.2004.0020.", "ArticleIdList": ["10.2166/wst.2004.0020", "15318488"]}, {"Citation": "Zhou K., Tian K.-Y., Liu X.-Q., Liu W., Zhang X.-Y., Liu J.-Y., Sun F. Characteristic and Otopathogenic Analysis of a Vibrio alginolyticus Strain Responsible for Chronic Otitis Externa in China. Front. Microbiol. 2021;12:750642. doi: 10.3389/fmicb.2021.750642.", "ArticleIdList": ["10.3389/fmicb.2021.750642", "PMC8718755", "34975783"]}, {"Citation": "Kim J.K., Cho J.H. Change of external auditory canal pH in acute otitis externa. Ann. Otol. Rhinol. Laryngol. 2009;118:769\u2013772. doi: 10.1177/000348940911801104.", "ArticleIdList": ["10.1177/000348940911801104", "19999361"]}, {"Citation": "Nussinovitch M., Rimon A., Volovitz B., Raveh E., Prais D., Amir J. Cotton-tip applicators as a leading cause of otitis externa. Int. J. Pediatr. Otorhinolaryngol. 2004;68:433\u2013435. doi: 10.1016/j.ijporl.2003.11.014.", "ArticleIdList": ["10.1016/j.ijporl.2003.11.014", "15013609"]}, {"Citation": "Yang T.-H., Xirasagar S., Cheng Y.-F., Wu C.-S., Kao Y.-W., Shia B.-C., Lin H.-C. Malignant Otitis Externa is Associated with Diabetes: A Population-Based Case-Control Study. Ann. Otol. Rhinol. Laryngol. 2020;129:585\u2013590. doi: 10.1177/0003489419901139.", "ArticleIdList": ["10.1177/0003489419901139", "31976744"]}, {"Citation": "Tsilivigkos C., Avramidis K., Ferekidis E., Doupis J. Malignant External Otitis: What the Diabetes Specialist Should Know-A Narrative Review. Diabetes Ther. 2023;14:629\u2013638. doi: 10.1007/s13300-023-01390-9.", "ArticleIdList": ["10.1007/s13300-023-01390-9", "PMC10064349", "36897495"]}, {"Citation": "Durojaiye O.C., Slucka A., Kritsotakis E.I. Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa. Eur. J. Clin. Microbiol. Infect. Dis. 2022;41:941\u2013949. doi: 10.1007/s10096-022-04455-y.", "ArticleIdList": ["10.1007/s10096-022-04455-y", "35556187"]}, {"Citation": "Kraus D.H., Rehm S.J., Kinney S.E. The evolving treatment of necrotizing external otitis. Laryngoscope. 1988;98:934\u2013939. doi: 10.1288/00005537-198809000-00006.", "ArticleIdList": ["10.1288/00005537-198809000-00006", "3412091"]}, {"Citation": "Forozidou E., Poutoglidis A., Tsetsos N., Kilmpasanis A., Fyrmpas G. Surgery as a Last Resort for Persistent Auricular Perichondritis. Ear Nose Throat J. 2021;10:1455613211038343. doi: 10.1177/01455613211038343.", "ArticleIdList": ["10.1177/01455613211038343", "34375535"]}, {"Citation": "Trevi\u00f1o Gonz\u00e1lez J.L., Reyes Su\u00e1rez L.L., Hern\u00e1ndez de Le\u00f3n J.E. Malignant otitis externa: An updated review. Am. J. Otolaryngol. 2021;42:102894. doi: 10.1016/j.amjoto.2020.102894.", "ArticleIdList": ["10.1016/j.amjoto.2020.102894", "33429178"]}, {"Citation": "Tognetto D., Pastore M.R., Guerin G.M., Decorti G., Franzin M., Lagatolla C., Cirigliano G. Bactericidal activity of three different antiseptic ophthalmic preparations as surgical prophylaxis. Graefes Arch. Clin. Exp. Ophthalmol. 2022;260:289\u2013293. doi: 10.1007/s00417-021-05361-3.", "ArticleIdList": ["10.1007/s00417-021-05361-3", "PMC8763824", "34427741"]}, {"Citation": "Cagini C., Mariniello M., Messina M., Muzi A., Balducci C., Moretti A., Levorato L., Mencacci A. The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: A randomized clinical trial. Int. Ophthalmol. 2020;40:3209\u20133215. doi: 10.1007/s10792-020-01503-4.", "ArticleIdList": ["10.1007/s10792-020-01503-4", "PMC7669761", "32696102"]}, {"Citation": "Zerillo L., Polvere I., Varricchio R., Madera J.R., D\u2019andrea S., Voccola S., Franchini I., Stilo R., Vito P., Zotti T. Antibiofilm and repair activity of ozonated oil in liposome. Microb. Biotechnol. 2022;15:1422\u20131433. doi: 10.1111/1751-7915.13949.", "ArticleIdList": ["10.1111/1751-7915.13949", "PMC9049609", "34773386"]}, {"Citation": "Rizzo S., Savastano M.C., Bortolotti D., Savastano A., Gambini G., Caccuri F., Gentili V., Rizzo R. COVID-19 Ocular Prophylaxis: The Potential Role of Ozonated-Oils in Liposome Eyedrop Gel. Transl. Vis. Sci. Technol. 2021;10:7. doi: 10.1167/tvst.10.9.7.", "ArticleIdList": ["10.1167/tvst.10.9.7", "PMC8354035", "34351367"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "4", "Day": "12"}, {"Year": "2023", "Month": "6", "Day": "1"}, {"Year": "2023", "Month": "6", "Day": "27"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "11", "Minute": "54"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "11", "Minute": "53"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "1", "Minute": "26"}, {"Year": "2023", "Month": "6", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["37511695", "PMC10381888", "10.3390/jpm13071083", "jpm13071083"]}}], "PubmedBookArticle": []}